Andrew Guggenhime, PRESIDENT AND CFO at Vaxcyte, Inc. (PCVX), sold 10,000 shares at $53.76 ($539K) on 2026-08-03, disclosed to the SEC on 2026-08-05.
Scheduled sale ($539k) by PRESIDENT AND CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.76 | 6,956 | $374K | 69.4% |
| 2 | $54.18 | 3,044 | $165K | 30.6% |
| Total | $53.89 avg | 10,000 | $539K | 100% |
| Filing → |
| PCVX | SELL | 2025-02-19 | $1.3M | — | Filing → |
| PCVX | SELL | 2025-01-22 | $1.4M | — | Filing → |
| PCVX | SELL | 2024-12-19 | $1.4M | — | Filing → |